Korea Health Personnel Licensing Examination Institute (KHPLEI; 한국보건의료인국가시험원). Pharmacist licensing authority: Minister of Health and Welfare, Republic of Korea. · KHPLEI current pharmacist examination subject/time table, accessed 2026-10-11, alongside its published 2027 examination cycle. Statutory topic outline: Pharmaceutical Affairs Act Enforcement Rule Article 2 and Annex 1; current Article 2 is in Ministry of Health and Welfare Ordinance No. 1181, effective 2026-06-21. The timetable has no separately stated syllabus version. Workbook label 'Korean Pharmacist Licensure Examination' maps descriptively to the official 약사 국가시험; the assigned slug is preserved.

This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.

• KHPLEI — Pharmacist profession and examination schedule
• KHPLEI — Pharmacist examination subjects and timetable
• KHPLEI Notice No. 2026-81 — 2026 second-half and 2027 first-half CBT examination plan
• Pharmaceutical Affairs Act Enforcement Decree — Article 4
• Pharmaceutical Affairs Act Enforcement Rule — Article 2
• Pharmaceutical Affairs Act Enforcement Rule — Annex 1: Pharmacist examination subject details
• Pharmaceutical Affairs Act — Article 24, effective 2026-10-08
• NCATS and Eli Lilly Assay Guidance Manual — Mechanism of Action Assays for Enzymes
• DailyMed — Amoxicillin capsule prescribing information
• DailyMed — Rosuvastatin prescribing information
• CDC Pink Book — Principles of Vaccination
• NIDDK — Type 1 Diabetes
• CDC — Clinical Guidance for Carbon Monoxide Poisoning
• OpenStax Chemistry 2e — Buffers
• FDA — Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Forms, August 2018
• ICH Q2(R2) — Validation of Analytical Procedures, EMA Step 5
• FDA — Development of New Stereoisomeric Drugs
• EMA — Quality of Herbal Medicinal Products, Revision 3, 18 January 2022
• FDA — Pharmacokinetics in Patients with Impaired Renal Function, March 2024
• DailyMed — Warfarin sodium prescribing information
• DailyMed — Lisinopril prescribing information, revised February 2026
• DailyMed — Fluticasone propionate HFA prescribing information
• FDA Safe Use Initiative — Oral liquid medication measurement
• FDA — COMBOGESIC prescribing information, 2024
• CDC Principles of Epidemiology — Measures of Public Health Impact
• FDA — Investigating Out-of-Specification Test Results for Pharmaceutical Production, May 2022
• ICH Q1E — Evaluation of Stability Data
• AHRQ — Use the Teach-Back Method, Tool 5
• AHRQ — Conduct Brown Bag Medicine Reviews, Tool 8
• EMA — Quality of Herbal Medicinal Products: Current Effective Version and Document History
• IUBMB Enzyme Nomenclature — Hydroxymethylglutaryl-CoA Synthase, EC 2.3.3.10
• IUBMB Enzyme Nomenclature — Mevalonate Kinase, EC 2.7.1.36
• IUBMB Enzyme Nomenclature — Squalene Monooxygenase, EC 1.14.14.17